Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 142

1.

Short-term blood pressure variability outweighs average 24-h blood pressure in the prediction of cardiovascular events in hypertension of the young.

Palatini P, Saladini F, Mos L, Fania C, Mazzer A, Cozzio S, Zanata G, Garavelli G, Biasion T, Spinella P, Vriz O, Casiglia E, Reboldi G.

J Hypertens. 2019 Mar 14. doi: 10.1097/HJH.0000000000002074. [Epub ahead of print]

PMID:
30882599
2.

Role of Optimal Medication Given to Patients with Hypertension and Ischemic Heart Disease Prior to an Acute Coronary Syndrome.

Pop C, Florescu R, Matei C, Pop L, Manea V, Cotoraci C, Mos L, Petris A.

Heart Int. 2017 Oct 14;12(1). pii: heartint.5000237. doi: 10.5301/heartint.5000237. eCollection 2017 Jan-Dec.

3.

Clinical characteristics and risk of hypertension needing treatment in young patients with systolic hypertension identified with ambulatory monitoring.

Palatini P, Saladini F, Mos L, Fania C, Mazzer A, Casiglia E.

J Hypertens. 2018 Sep;36(9):1810-1815. doi: 10.1097/HJH.0000000000001754.

PMID:
30005026
4.

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.

Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, Xavier D, Szczeklik W, Meyhoff CS, Vincent J, Franzosi MG, Srinathan SK, Erb J, Magloire P, Neary J, Rao M, Rahate PV, Chaudhry NK, Mayosi B, de Nadal M, Iglesias PP, Berwanger O, Villar JC, Botto F, Eikelboom JW, Sessler DI, Kearon C, Pettit S, Sharma M, Connolly SJ, Bangdiwala SI, Rao-Melacini P, Hoeft A, Yusuf S; MANAGE Investigators.

Lancet. 2018 Jun 9;391(10137):2325-2334. doi: 10.1016/S0140-6736(18)30832-8. Erratum in: Lancet. 2018 Jul 7;392(10141):30.

PMID:
29900874
5.

Low night-time heart rate is longitudinally associated with lower augmentation index and central systolic blood pressure in hypertension.

Palatini P, Saladini F, Mos L, Fania C, Mazzer A, Casiglia E.

Eur J Appl Physiol. 2018 Mar;118(3):543-550. doi: 10.1007/s00421-017-3789-4. Epub 2018 Jan 2.

PMID:
29294160
6.

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators.

Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.

7.

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Connolly SJ, Eikelboom JW, Bosch J, Dagenais G, Dyal L, Lanas F, Metsarinne K, O'Donnell M, Dans AL, Ha JW, Parkhomenko AN, Avezum AA, Lonn E, Lisheng L, Torp-Pedersen C, Widimsky P, Maggioni AP, Felix C, Keltai K, Hori M, Yusoff K, Guzik TJ, Bhatt DL, Branch KRH, Cook Bruns N, Berkowitz SD, Anand SS, Varigos JD, Fox KAA, Yusuf S; COMPASS investigators.

Lancet. 2018 Jan 20;391(10117):205-218. doi: 10.1016/S0140-6736(17)32458-3. Epub 2017 Nov 10. Erratum in: Lancet. 2017 Dec 21;:.

PMID:
29132879
8.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

9.

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.

N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.

10.

Office Pulse Pressure Is a Predictor of Favorable Outcome in Young- to Middle-Aged Subjects With Stage 1 Hypertension.

Saladini F, Fania C, Mos L, Mazzer A, Casiglia E, Palatini P.

Hypertension. 2017 Jul 24. pii: HYPERTENSIONAHA.117.09516. doi: 10.1161/HYPERTENSIONAHA.117.09516. [Epub ahead of print]

PMID:
28739974
11.

Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.

Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI‐HF Investigators.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005156. doi: 10.1161/JAHA.116.005156.

12.

Carcinoid Heart Disease: Starting From Heart Failure.

Bertin N, Favretto S, Pelizzo F, Mos L, Pertoldi F, Vriz O.

J Investig Med High Impact Case Rep. 2017 Jun 8;5(2):2324709617713511. doi: 10.1177/2324709617713511. eCollection 2017 Apr-Jun.

13.

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators.

N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581.

14.

Alcohol Intake More than Doubles the Risk of Early Cardiovascular Events in Young Hypertensive Smokers.

Palatini P, Fania C, Mos L, Mazzer A, Saladini F, Casiglia E.

Am J Med. 2017 Aug;130(8):967-974.e1. doi: 10.1016/j.amjmed.2017.02.041. Epub 2017 Mar 31.

PMID:
28366424
15.

Regular physical activity prevents development of hypertension in young people with hyperuricemia.

Saladini F, Mos L, Fania C, Garavelli G, Casiglia E, Palatini P.

J Hypertens. 2017 May;35(5):994-1001. doi: 10.1097/HJH.0000000000001271.

PMID:
28118282
16.

In-hospital and long-term mortality in Takotsubo cardiomyopathy: a community hospital experience.

Vriz O, Brosolo G, Martina S, Pertoldi F, Citro R, Mos L, Ferrara F, Bossone E.

J Community Hosp Intern Med Perspect. 2016 Jul 6;6(3):31082. doi: 10.3402/jchimp.v6.31082. eCollection 2016.

17.

Effects of smoking on central blood pressure and pressure amplification in hypertension of the young.

Saladini F, Benetti E, Fania C, Mos L, Casiglia E, Palatini P.

Vasc Med. 2016 Oct;21(5):422-428. Epub 2016 May 19.

PMID:
27197683
18.

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.

McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM; ATMOSPHERE Committees Investigators.

N Engl J Med. 2016 Apr 21;374(16):1521-32. doi: 10.1056/NEJMoa1514859. Epub 2016 Apr 4.

19.

Coffee consumption and risk of cardiovascular events in hypertensive patients. Results from the HARVEST.

Palatini P, Fania C, Mos L, Garavelli G, Mazzer A, Cozzio S, Saladini F, Casiglia E.

Int J Cardiol. 2016 Jun 1;212:131-7. doi: 10.1016/j.ijcard.2016.03.006. Epub 2016 Mar 17.

PMID:
27038718
20.

Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.

Redon J, Pichler G; Missed Dose Study Group.

J Hypertens. 2016 Feb;34(2):359-67. doi: 10.1097/HJH.0000000000000793.

PMID:
26867060

Supplemental Content

Loading ...
Support Center